Tenders/MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration

MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration

European Union Drugs Agency

Published: Sep 22, 2026

Updated: Sep 22, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a services contract in the Research sector, with a focus on Scientific Research, Data Science and Laboratories. Located in Portugal, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the Research sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Regulation (EU) 2023/1322, which establishes the European Union Drugs Agency (EUDA), strengthens the Union’s preparedness for, and response to, drug-related health and security challenges. Article 15 in particular provides for a dedicated network of forensic and toxicology laboratories to enhance analytical capacity, harmonise methods, support quality assurance and facilitate the exchange of data and expertise across Member States. This strengthens and supports the timely detection, assessment and response to drug-related risks. Within this policy context, systematic investigation of drug metabolism is a cornerstone of clinical and forensic toxicology. Overall, the objective of this contract is to reinforce collective capacity across the EU to interpret toxicological findings and, critically, to improve the detection, identification, and timely reporting of exposure to NPS and other illicit drugs. By generating robust metabolic, pharmacological, and analytical data, and by consolidating these outputs into a centralised, accessible EU database, the project aims to strengthen timely reporting, harmonise practices, and ensure that toxicological evidence can be translated more effectively into monitoring, early warning, and public health responses to emerging NPS threats.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 22, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About European Union Drugs Agency

European Union Drugs Agency has issued 10 procurement notices on BidsFactory, including 2 currently open and 2 awarded contracts. Activity concentrates in Research & Innovation, General Supplies & Services, and Industry & Manufacturing. All notices are published for Portugal. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: September 22, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by European Union Drugs Agency in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Services contract in the Research & Innovation sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.